Gleiss Lutz advised Topcon Europe Medical B.V., an indirect subsidiary of the Japanese Topcon Corporation, on the sale of its majority interest in ifa systems AG to Nexus AG.
Topcon is a Japanese manufacturer of optical devices for use in ophthalmology and optometrics, with around 4,450 employees worldwide. Topcon Corporation is listed on the Tokyo Stock Exchange.
ifa systems AG is one of the leading providers of software, IT services, web applications and medical information systems in the field of eye care. Headquartered in Frechen near Cologne, the company went public in 2005 and is currently listed in the Open Market segment (WKN 783078).
The Gleiss Lutz team was headed by partner Dr. Michael Burian (Picture), Dr. Stephan Aubel (partner, corporate/capital markets, Frankfurt, both lead), Dr. Martin Lembke (counsel) and Dr. Maike Sauter (all corporate/M&A, Stuttgart), and also included Jan-Rasmus Roßkamp (corporate/capital markets, Frankfurt), Dr. Christopher Vogl (corporate/M&A, Stuttgart), Dr. Alexander Molle (partner) and Dr. Hannah Bug (both IP/IT, Berlin).
Involved fees earner: Stephan Aubel – Gleiss Lutz; Hannah Bug – Gleiss Lutz; Michael Burian – Gleiss Lutz; Martin Lembke – Gleiss Lutz; Alexander Molle – Gleiss Lutz; Jan-Rasmus Roßkamp – Gleiss Lutz; Maike Sauter – Gleiss Lutz; Christopher Vogl – Gleiss Lutz;
Law Firms: Gleiss Lutz;
Clients: Topcon Europe Medical;